HOME >> MEDICINE >> NEWS
Media invited to international conference on bipolar disorder June 16-18 in Pittsburgh

PITTSBURGH, May 18 More than 1,000 researchers, clinicians and mental health advocates are expected to attend the Sixth International Conference on Bipolar Disorder June 16-18 at the David L. Lawrence Convention Center in Pittsburgh. New research will be presented covering the pathophysiology, assessment and treatment of bipolar illness, as well as on psychobiology, epidemiology and the psychosocial issues that affect the more than 2 million American adults with the disease. Media are invited to attend.

The first two days of the program will consist of scientific sessions, including 10 presentations of late-breaking research. Saturday's program will be geared toward both clinicians and individuals who have bipolar disorder and their families. Topics to be presented include:

  • Genetic profiles and vulnerabilities that may predict who will get bipolar disorder
  • Treatment approaches that reduce suicide in bipolar patients
  • Societal costs and the functional and economic burden of bipolar disorder
  • Ethical considerations for designing clinical trials that involve placebos

A staffed press room will be available on site and media briefings will be held Thursday and Friday. To register as press, please contact Lisa Rossi at rossil@upmc.edu or Gloria Kreps at nbintern2@upmc.edu or call the University of Pittsburgh Medical Center's News Bureau at (412) 647-3555. The preliminary scientific program and hotel information are available at www.6thbipolar.org.

As with all previous meetings, the Sixth International Conference on Bipolar Disorder is being sponsored by the University of Pittsburgh School of Medicine and Western Psychiatric Institute and Clinic of the University of Pittsburgh Medical Center.


'"/>


18-May-2005


Page: 1

Related medicine news :

1. Media coverage of autism differs dramatically
2. Media availability: New results show some severe emphysema patients continue to benefit from surgery
3. Media availability: Drug found to help scleroderma patients
4. Media alert: Register now for the largest obesity conference in North America
5. Media availability: Long-term survival of heart attack patients with shock
6. The IOF World Congress on Osteoporosis (IOF WCO) Opening Media Briefing June 2
7. Webcast: Media coverage of health
8. Media alert: Hazeldens chief medical director available to comment on drug treatment for alcoholics
9. Media telebriefing on new census, NIH status report citing dramatic shifts in US aging
10. Media invitation: 4th International Conference on Teenage and Young Adult Cancer Medicine
11. Media violence linked to concentration, self-control

Post Your Comments:
(Date:5/22/2013)... 2013 - Research presented today shows that high-fructose ... similar to those produced by drugs of abuse ... addiction expert Francesco Leri, Associate Professor of Neuroscience ... Guelph, suggest food addiction could explain, at least ... results were presented at the 2013 Canadian Neuroscience ...
(Date:5/22/2013)... 2013: New research shows that craving drugs such ... of the brain that are implicated in determining ... in motivation. Dr. Alain Dagher, from McGill ... regions could underlie addiction. These results were presented ... meeting of the Canadian Association for Neuroscience - ...
(Date:5/22/2013)... will publish details of a technique to measure the ... age. The method is demonstrated by the laboratory of Dr. ... Dr. Atzmon hopes that the dissemination of this technique will ... a patients health in relation to other individuals of the ... a technique that measures telomere length. Recently, telomeres have gained ...
(Date:5/22/2013)... -- Use of the antidepressant Lexapro appears to ... a new study finds. The condition ... ischemia." Although people with this condition may not ... receiving adequate blood supply, according to researchers from ... However, the researchers found that people taking ...
(Date:5/22/2013)... , , TUESDAY, May 21 (HealthDay News) -- The overall ... in 10 people either overweight or obese and large ... or not exercising, a new government report shows. , ... Control and Prevention, the report found Americans continuing to ... to soaring rates of heart disease, diabetes and other ...
Breaking Medicine News(10 mins):Health News:Addiction to unhealthy foods could help explain the global obesity epidemic 2Health News:Addiction as a disorder of decision-making 2Health News:How healthy are you for your age? 2Health News:Antidepressants May Be Helpful for Some Heart Patients: Study 2Health News:Antidepressants May Be Helpful for Some Heart Patients: Study 3Health News:Americans Still Making Unhealthy Choices: CDC 2Health News:Americans Still Making Unhealthy Choices: CDC 3
(Date:5/22/2013)... N.Y. , May 22, 2013  MGT Capital ... Company will present at the Second Annual Marcum LLP ... New York City at the Grand ... and Chief Executive Officer, will update investors and answer ... The Company,s presentation is scheduled to begin at ...
(Date:5/22/2013)... MAPLE GROVE, Minn. , May 22, ... today announced the successful completion of its ... (extended-release topiramate), an internally developed program for ... the company,s proprietary formulation technology.  USL255 is ... and reduce fluctuations in topiramate blood levels ...
(Date:5/22/2013)... , May 22, 2013 Hemoglobin A1C ... patients with Type 2 diabetes, while modest improvements ... health outcomes and can lead to substantial healthcare ... the International Society for Pharmacoeconomics and Outcomes Research ... two studies, sponsored by Valeritas, makers of the ...
Breaking Medicine Technology:MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 3MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 4Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 3Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 4Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 2Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 3Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 4Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 5Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 6
Cached News: